Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
CTEV	CLARITEV CORP	$381.74M	N/A	-6.70%	-1.64%	-1.60%	-50.00	1.21	74.70%	-35.90%	-8.25%
TOI	ONCOLOGY INSTITUTE INC	$261.69M	N/A	-36.70%	-51.13%	-32.30%	-14.33	1.68	14.80%	-13.10%	-10.87%
LENZ	LENZ THERAPEUTICS INC	$408.02M	-29.60%	-27.90%	-30.03%	-33.60%	0.09	12.69	100.00%	-336.50%	-333.61%
RARE	ULTRAGENYX PHARMACEUTICAL INC	$1.95B	-436.00%	-43.70%	-67.82%	-38.30%	543.90	1.89	84.70%	-91.90%	-91.46%
RPID	RAPID MICRO BIOSYSTEMS INC	$174.63M	-73.90%	-51.60%	-66.72%	-73.80%	0.90	4.23	7.70%	-145.10%	-148.33%
EDIT	EDITAS MEDICINE INC	$169.86M	-348.50%	-78.60%	-143.62%	-160.90%	14.00	2.86	100.00%	-430.80%	-433.42%
SY	SO-YOUNG INTERNATIONAL INC	$308.88M	-42.20%	-27.80%	-37.41%	-67.70%	0.51	2.20	51.60%	-51.80%	-51.50%
ABCL	ABCELLERA BIOLOGICS INC	$948.89M	-17.00%	-12.60%	-15.92%	-17.70%	0.41	10.10	100.00%	-486.00%	-580.13%
EQ	EQUILLIUM INC	$96.82M	-148.80%	-109.40%	-76.58%	1,073.10%	0.12	10.85	100.00%	-555.90%	-547.72%
CTNM	CONTINEUM THERAPEUTICS INC	$428.69M	-32.30%	-30.30%	-32.19%	-35.60%	0.06	29.07	N/A	N/A	N/A
EVO	EVOTEC SE	$1.25B	-18.10%	-8.50%	-8.37%	-8.40%	1.22	2.12	10.80%	-21.00%	-15.47%
EPRX	EUPRAXIA PHARMACEUTICALS INC	$295.95M	-67.40%	-65.30%	-33.21%	20,901.30%	0.04	23.98	N/A	N/A	N/A
TVRD	TVARDI THERAPEUTICS INC	$34.24M	-115.90%	-33.70%	-31.65%	-30.90%	0.40	3.48	100.00%	-346.50%	-220.05%
VYGR	VOYAGER THERAPEUTICS INC	$189.60M	-48.90%	-37.40%	-49.86%	-45.70%	0.31	6.19	100.00%	-404.80%	-402.55%
RDY	DR REDDYS LABORATORIES LTD	$12.02B	18.40%	12.80%	21.76%	28.70%	0.47	1.92	58.50%	17.40%	24.24%
TNYA	TENAYA THERAPEUTICS INC	$105.07M	-95.50%	-76.80%	-102.71%	-122.30%	0.27	4.64	N/A	N/A	N/A
MLYS	MINERALYS THERAPEUTICS INC	$2.21B	-48.20%	-45.80%	-29.73%	-83.20%	0.04	25.50	N/A	N/A	N/A
PYPD	POLYPID LTD	$69.03M	-312.80%	-120.70%	-134.93%	-203.00%	0.84	2.28	N/A	N/A	N/A
NRXS	NEURAXIS INC	$57.42M	-377.70%	-162.10%	-284.96%	703.70%	1.53	1.59	84.30%	-249.00%	-222.82%
MPLT	MAPLIGHT THERAPEUTICS INC	$782.68M	N/A	N/A	N/A	N/A	-0.09	13.22	N/A	N/A	N/A
CV	CAPSOVISION INC	$228.59M	N/A	N/A	N/A	N/A	0.26	5.19	N/A	N/A	N/A
ARVN	ARVINAS INC	$734.73M	-9.80%	-6.10%	-8.39%	-8.60%	0.50	5.70	100.00%	-18.70%	-18.80%
SVRA	SAVARA INC	$1.17B	-86.60%	-65.40%	-93.14%	-66.40%	0.49	7.65	N/A	N/A	N/A
COEP	COEPTIS THERAPEUTICS HOLDINGS INC	$64.08M	-172.70%	-92.60%	-95.84%	-192.70%	0.32	2.21	73.00%	-2,251.50%	-2,195.46%
PLRX	PLIANT THERAPEUTICS INC	$69.44M	-71.50%	-53.30%	-66.51%	-62.10%	0.38	13.94	N/A	N/A	N/A
ICU	SEASTAR MEDICAL HOLDING CORP	$8.72M	-414.50%	-151.10%	-121.21%	425.70%	0.36	3.66	95.30%	-1,551.10%	-1,577.19%
DSGN	DESIGN THERAPEUTICS INC	$576.47M	-30.60%	-29.20%	-33.62%	-32.80%	0.06	18.71	N/A	N/A	N/A
VYNE	VYNE THERAPEUTICS INC	$19.59M	-80.60%	-66.00%	-104.91%	-173.00%	0.13	8.87	100.00%	-6,425.20%	-6,424.43%
ACTU	ACTUATE THERAPEUTICS INC	$99.02M	-2,924.50%	-250.70%	-212.50%	311.00%	0.62	2.74	N/A	N/A	N/A
CLOV	CLOVER HEALTH INVESTMENTS CORP	$1.05B	-17.10%	-10.10%	-15.93%	-31.80%	0.64	1.71	21.20%	-3.30%	-3.29%
TERN	TERNS PHARMACEUTICALS INC	$3.57B	-30.00%	-28.50%	-32.91%	-55.60%	0.06	19.52	N/A	N/A	N/A
NNVC	NANOVIRICIDES INC	$22.24M	-96.20%	-84.30%	-75.13%	-145.00%	0.11	4.43	N/A	N/A	N/A
BIOA	BIOAGE LABS INC	$703.83M	-25.10%	-22.80%	-26.68%	-137.60%	0.10	11.87	100.00%	-1,280.90%	-1,265.29%
RNXT	RENOVORX INC	$35.92M	-122.20%	-90.70%	-123.25%	3,053.60%	0.39	5.83	67.80%	-1,196.70%	-1,238.04%
IMNM	IMMUNOME INC	$2.08B	-87.20%	-75.60%	-83.13%	-373.20%	0.13	8.90	100.00%	-2,301.30%	-2,301.30%
PROK	PROKIDNEY CORP	$607.69M	N/A	-18.10%	-20.87%	-24.90%	-0.03	10.32	100.00%	-9,547.40%	-9,049.33%
NRXP	NRX PHARMACEUTICALS INC	$50.58M	N/A	-489.90%	148.69%	172.10%	-1.58	0.29	59.90%	-15,727.70%	-15,727.69%
SAVA	CASSAVA SCIENCES INC	$100.96M	-95.80%	-75.30%	-129.80%	2,002.20%	0.59	2.27	N/A	N/A	N/A
APLM	APOLLOMICS INC	$22.32M	-380.10%	-136.50%	-4,767.85%	1,243.90%	-3.53	0.97	100.00%	-366.90%	-362.92%
PHVS	PHARVARIS NV	$1.73B	-66.20%	-60.20%	N/A	-1,563.70%	0.09	N/A	N/A	N/A	N/A
KTTA	PASITHEA THERAPEUTICS CORP	$5.16M	-97.90%	-88.00%	-110.13%	5,105.70%	0.12	4.02	N/A	N/A	N/A
LIXT	LIXTE BIOTECHNOLOGY HOLDINGS INC	$17.23M	-219.00%	-178.10%	-82.92%	-1,205.80%	0.11	10.42	N/A	N/A	N/A
OCUL	OCULAR THERAPEUTIX INC	$1.52B	-71.70%	-51.20%	-33.56%	-272.30%	0.24	15.39	87.30%	-511.90%	-489.12%
LNAI	LUNAI BIOWORKS INC	$16.13M	-1,241.30%	-359.70%	936.64%	728.20%	-1.49	0.03	N/A	N/A	N/A
ALXO	ALX ONCOLOGY HOLDINGS INC	$123.07M	-138.90%	-96.70%	-193.39%	-132.10%	0.85	2.40	N/A	N/A	N/A
CANF	CAN-FITE BIOPHARMA LTD	$2.92M	-264.10%	-129.00%	-157.13%	1,180.30%	0.85	3.60	100.00%	-1,571.30%	-1,571.25%
VTGN	VISTAGEN THERAPEUTICS INC	$21.00M	-109.70%	-89.60%	-130.12%	-918.60%	0.28	4.68	100.00%	-8,486.80%	-8,486.84%
GLPG	GALAPAGOS NV	$2.24B	-16.20%	-11.30%	-14.48%	-14.00%	0.44	8.63	71.10%	-151.40%	-158.11%
IRD	OPUS GENETICS INC	$268.27M	-774.20%	-170.70%	-968.51%	467.50%	5.05	1.24	100.00%	-466.10%	-465.63%
ELTX	ELICIO THERAPEUTICS INC	$150.23M	-5,657.90%	-160.70%	-205.92%	-320.10%	6.41	3.30	N/A	N/A	N/A
LPCN	LIPOCINE INC	$52.47M	-30.60%	-28.20%	-38.71%	-42.10%	0.14	8.25	100.00%	-126.70%	-126.66%
QTRX	QUANTERIX CORP	$269.05M	-30.50%	-23.60%	-27.57%	-38.70%	0.41	3.02	51.50%	-73.50%	-77.68%
RBOT	VICARIOUS SURGICAL INC	$11.52M	-181.80%	-111.10%	-204.78%	-107.50%	1.08	4.75	N/A	N/A	N/A
ABOS	ACUMEN PHARMACEUTICALS INC	$148.40M	-97.40%	-70.40%	-107.41%	-81.60%	0.53	6.02	N/A	N/A	N/A
TLRY	TILRAY BRANDS INC	$874.97M	-114.80%	-87.50%	-120.17%	-196.50%	0.35	2.81	28.00%	-252.20%	-263.98%
IMVT	IMMUNOVANT INC	$5.35B	-65.80%	-60.40%	-46.70%	25,054.10%	0.07	15.74	N/A	N/A	N/A
ZBIO	ZENAS BIOPHARMA INC	$1.44B	-73.50%	-57.60%	-70.35%	-174.50%	0.64	5.66	100.00%	-1,266.00%	-1,264.37%
STIM	NEURONETICS INC	$97.93M	-151.30%	-31.60%	-31.45%	-27.20%	4.17	2.24	50.40%	-34.30%	-28.22%
TMCI	TREACE MEDICAL CONCEPTS INC	$116.60M	-49.50%	-24.30%	-28.79%	-21.80%	1.20	3.37	79.90%	-22.90%	-20.48%
ALLO	ALLOGENE THERAPEUTICS INC	$485.42M	-57.80%	-43.10%	-51.66%	-53.00%	0.40	8.19	N/A	N/A	N/A
ACON	ACLARION INC	$1.74M	-68.00%	-63.50%	-58.67%	2,444.20%	0.06	17.01	-7.80%	-10,948.20%	-10,867.45%
STOK	STOKE THERAPEUTICS INC	$1.78B	13.30%	11.40%	8.62%	16.40%	0.17	6.53	100.00%	19.70%	13.35%
DCOY	DECOY THERAPEUTICS INC	$4.40M	-401.00%	-155.80%	-117.81%	443.70%	0.44	3.28	N/A	N/A	N/A
TELO	TELOMIR PHARMACEUTICALS INC	$39.54M	-566.60%	-447.90%	-161.29%	2,487.30%	0.06	17.51	N/A	N/A	N/A
APVO	APTEVO THERAPEUTICS INC	$6.69M	-411.10%	-168.00%	-123.81%	-519.70%	0.55	4.03	N/A	N/A	N/A
PLSE	PULSE BIOSCIENCES INC	$1.60B	-69.40%	-60.40%	-75.44%	-786.50%	0.17	10.02	-224.40%	-86,898.80%	-86,898.84%
BDRX	BIODEXA PHARMACEUTICALS PLC	$0.00	-244.80%	-171.40%	-217.16%	-1,804.70%	0.30	3.63	100.00%	-3,171.60%	-3,445.89%
PGEN	PRECIGEN INC	$1.84B	-5,766.20%	-311.30%	-176.76%	-238.60%	3.09	4.04	30.30%	-6,750.10%	-3,899.94%
TAOX	TAO SYNERGIES INC	$28.02M	-244.20%	-152.10%	-153.61%	-540.70%	0.11	17.61	100.00%	-13,058.70%	-12,829.93%
CRNX	CRINETICS PHARMACEUTICALS INC	$4.14B	-35.10%	-32.00%	-37.71%	-36.00%	0.12	15.12	100.00%	-27,563.30%	-27,563.32%
IMTX	IMMATICS NV	$1.21B	-23.30%	-19.10%	-26.21%	-40.90%	0.24	7.36	100.00%	-136.70%	-141.11%
QNTM	QUANTUM BIOPHARMA LTD	$14.16M	-384.90%	-185.60%	-370.55%	-12,582.70%	0.77	1.41	N/A	N/A	N/A
KYTX	KYVERNA THERAPEUTICS INC	$332.41M	-77.90%	-65.80%	-104.98%	-103.60%	0.23	5.16	N/A	N/A	N/A
ACRV	ACRIVON THERAPEUTICS INC	$50.49M	-53.70%	-48.30%	-62.69%	-69.00%	0.13	8.75	N/A	N/A	N/A
MAZE	MAZE THERAPEUTICS INC	$2.26B	-65.20%	-31.20%	-31.61%	-208.60%	0.11	17.70	N/A	N/A	N/A
BEAM	BEAM THERAPEUTICS INC	$2.79B	-42.90%	-31.50%	-36.74%	-43.30%	0.36	6.02	100.00%	-744.40%	-744.41%
BLTE	BELITE BIO INC	$5.60B	N/A	N/A	N/A	N/A	0.03	34.37	N/A	N/A	N/A
IVF	INVO FERTILITY INC	$1.93M	-475.60%	-100.40%	-293.09%	-7,843.00%	2.22	0.12	39.20%	-420.60%	-404.68%
KURA	KURA ONCOLOGY INC	$737.91M	-65.40%	-30.60%	-40.35%	-41.40%	1.68	5.12	100.00%	-208.50%	-204.82%
SANA	SANA BIOTECHNOLOGY INC	$1.03B	-120.60%	-53.80%	-58.61%	-127.50%	1.23	4.56	N/A	N/A	N/A
RMTI	ROCKWELL MEDICAL INC	$40.59M	-16.80%	-9.90%	-9.16%	-13.10%	0.55	3.92	15.10%	-7.30%	-5.81%
NERV	MINERVA NEUROSCIENCES INC	$45.11M	N/A	-43.70%	-55.18%	-24.10%	-1.81	4.87	N/A	N/A	N/A
KLRS	KALARIS THERAPEUTICS INC	$154.58M	-76.00%	-52.30%	-66.92%	-1,029.20%	0.94	12.89	N/A	N/A	N/A
ALEC	ALECTOR INC	$215.03M	-123.00%	-27.50%	-42.18%	-38.10%	4.81	3.76	100.00%	-156.00%	-155.96%
FULC	FULCRUM THERAPEUTICS INC	$576.90M	-32.20%	-30.00%	-34.99%	-38.20%	0.08	17.70	N/A	N/A	N/A
MTVA	METAVIA INC	$3.39M	-229.50%	-105.30%	-256.14%	214.30%	1.33	1.74	N/A	N/A	N/A
ACIU	AC IMMUNE SA	$293.60M	-83.50%	-35.80%	-97.78%	-248.70%	1.75	1.16	100.00%	-1,643.90%	-1,639.75%
IBIO	IBIO INC	$79.10M	-71.30%	-57.90%	-41.99%	-149.60%	0.14	9.04	100.00%	-8,245.70%	-8,187.33%
OM	OUTSET MEDICAL INC	$59.51M	-55.00%	-28.90%	-29.53%	-22.70%	1.08	6.67	39.10%	-68.30%	-56.06%
PAVM	PAVMED INC	$10.16M	-2.10%	-1.40%	11.29%	8.40%	0.38	0.40	-520.70%	-2,051.70%	10,751.72%
UFPT	UFP TECHNOLOGIES INC	$1.90B	18.00%	10.50%	16.36%	23.30%	0.62	2.41	28.50%	11.20%	15.61%
GPCR	STRUCTURE THERAPEUTICS INC	$4.33B	-26.10%	-24.70%	-27.14%	-31.10%	0.08	14.15	N/A	N/A	N/A
ANIX	ANIXA BIOSCIENCES INC	$96.12M	-66.60%	-62.80%	-77.43%	-76.90%	0.14	8.08	N/A	N/A	N/A
MCRB	SERES THERAPEUTICS INC	$74.91M	15.30%	3.60%	4.46%	3.60%	2.28	2.30	100.00%	1,536.80%	1,536.75%
WVE	WAVE LIFE SCIENCES LTD	$2.10B	-75.60%	-43.00%	-78.43%	504.40%	0.88	2.51	100.00%	-111.60%	-111.64%
PALI	PALISADE BIO INC	$253.31M	-240.70%	-137.30%	-320.89%	577.10%	1.17	1.96	N/A	N/A	N/A
LCTX	LINEAGE CELL THERAPEUTICS INC	$386.95M	-118.80%	-66.80%	-84.30%	3,452.30%	3.12	4.50	97.80%	-625.50%	-625.53%
TLSI	TRISALUS LIFE SCIENCES INC	$238.33M	N/A	-214.90%	-134.68%	-97.00%	-2.36	3.06	84.00%	-174.20%	-85.60%
ENLV	ENLIVEX THERAPEUTICS LTD	$26.72M	-62.90%	-53.30%	-82.65%	-29,748.70%	0.20	6.43	N/A	N/A	N/A
HURA	TUHURA BIOSCIENCES INC	$57.92M	-221.90%	-141.90%	-178.58%	-2,355.40%	0.53	0.40	N/A	N/A	N/A

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	610	+1.46%	+0.32%	-0.48%	-29.81%	203.20x	5.16x	-23.77%	-9.51%	-6.53%	+67.37%	Strong Buy
Diagnostics & Research	56	-0.40%	-4.39%	-12.07%	+6.08%	16.70x	3.97x	-4.44%	+6.36%	+11.82%	+22.58%	Buy
Drug Manufacturers - General	20	+0.36%	+2.68%	+8.12%	+28.89%	43.99x	7.33x	+100.80%	+12.44%	+21.08%	+4.47%	Buy
Drug Manufacturers - Specialty & Generic	75	+1.04%	-0.27%	+0.71%	-27.50%	-166.20x	1.75x	+9.97%	+2.28%	+5.20%	+42.63%	Buy
Healthcare Plans	10	-0.35%	+4.19%	-12.63%	-24.67%	19.38x	1.91x	+11.67%	+3.66%	+8.52%	+20.65%	Buy
Health Information Services	54	+0.76%	-3.56%	-18.69%	-91.47%	27.39x	3.20x	+8.66%	+4.39%	+6.53%	+66.23%	Buy
Medical Care Facilities	50	-0.09%	+5.82%	+12.69%	-30.49%	16.89x	5.91x	-68.69%	+7.69%	+15.92%	+10.21%	Buy
Medical Devices	139	+1.82%	-1.81%	-5.06%	-84.07%	21.83x	3.65x	+11.89%	+7.22%	+9.67%	+41.83%	Strong Buy
Medical Distribution	10	+0.90%	+0.77%	+10.03%	+52.80%	32.39x	277.72x	-98.61%	+3.54%	+23.66%	+2.69%	Buy
Medical Instruments & Supplies	57	+0.57%	-0.94%	-3.87%	-14.92%	171.28x	3.06x	+9.60%	+8.37%	+10.83%	+23.32%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Feb 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Pediatrix Medical Group (NYSE:MD)

Pediatrix Medical Group (NYSE:MD) is the #1 top healthcare stock out of 1081 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Pediatrix Medical Group (NYSE:MD) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: B, Financials: B, and AI: C.

Pediatrix Medical Group (NYSE:MD) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 14 out of 33 due diligence checks and has strong fundamentals. Pediatrix Medical Group has seen its stock return 51.92% over the past year, overperforming other healthcare stocks by 105 percentage points.

Pediatrix Medical Group has an average 1 year price target of $21.33, a downside of -1.74% from Pediatrix Medical Group's current stock price of $21.71.

Pediatrix Medical Group stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Pediatrix Medical Group, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #2 top healthcare stock out of 1081 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: A, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 30, which is 4 points higher than the healthcare sector average of 26. It passed 10 out of 33 due diligence checks and has average fundamentals. Bioventus has seen its stock lose -19.35% over the past year, overperforming other healthcare stocks by 33 percentage points.

Bioventus has an average 1 year price target of $13.00, an upside of 55.13% from Bioventus's current stock price of $8.38.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the #3 top healthcare stock out of 1081 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ironwood Pharmaceuticals (NASDAQ:IRWD) is: Value: A, Growth: B, Momentum: B, Sentiment: C, Safety: C, Financials: A, and AI: C.

Ironwood Pharmaceuticals (NASDAQ:IRWD) has a Due Diligence Score of 40, which is 14 points higher than the healthcare sector average of 26. It passed 13 out of 33 due diligence checks and has average fundamentals. Ironwood Pharmaceuticals has seen its stock return 139% over the past year, overperforming other healthcare stocks by 192 percentage points.

Ironwood Pharmaceuticals has an average 1 year price target of $6.50, an upside of 35.98% from Ironwood Pharmaceuticals's current stock price of $4.78.

Ironwood Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Ironwood Pharmaceuticals, 0% have issued a Strong Buy rating, 50% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 68 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 29.06%, which is 27 percentage points higher than the healthcare sector average of 2.26%.

Dominari Holdings's dividend payout ratio of 8.4% indicates that its high dividend yield is sustainable for the long-term.

2. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 9.1%, which is 7 percentage points higher than the healthcare sector average of 2.26%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 154.3% indicates that its high dividend yield might not be sustainable for the long-term.

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 7.81%, which is 6 percentage points higher than the healthcare sector average of 2.26%.

Oramed Pharmaceuticals's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.81% in the last day, and down -0.2% over the last week. Polaryx Therapeutics was the among the top gainers in the healthcare sector, gaining 64.32% yesterday.

Polaryx shares are trading higher after the company announced it selected a contract research organization for SOTERIA to evaluate PLX-200, across four different LSDs.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 86, which is 68 points higher than the healthcare sector average of 18. It passed 6 out of 7 valuation due diligence checks.

Embecta's stock has dropped -32.88% in the past year. It has overperformed other stocks in the healthcare sector by 20 percentage points.

2. Nutex Health (NASDAQ:NUTX)

Nutex Health (NASDAQ:NUTX) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Nutex Health has a valuation score of 57, which is 39 points higher than the healthcare sector average of 18. It passed 4 out of 7 valuation due diligence checks.

Nutex Health's stock has gained 53.58% in the past year. It has overperformed other stocks in the healthcare sector by 106 percentage points.

3. Organon & Co (NYSE:OGN)

Organon & Co (NYSE:OGN) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Organon & Co has a valuation score of 71, which is 53 points higher than the healthcare sector average of 18. It passed 5 out of 7 valuation due diligence checks.

Organon & Co's stock has dropped -52.97% in the past year. It has performed in line with other stocks in the healthcare sector.

Are healthcare stocks a good buy now?

57.82% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 39.3% over the next year.

6.59% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.93% of healthcare stocks are rated B (Buy), 46.95% are rated C (Hold), 25.03% are rated D (Sell), and 8.5% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 59.51x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Pediatrix Medical Group (NYSE:MD)

2. Bioventus (NASDAQ:BVS)

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Embecta (NASDAQ:EMBC)

2. Nutex Health (NASDAQ:NUTX)

3. Organon & Co (NYSE:OGN)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Pediatrix Medical Group (NYSE:MD)

2. Bioventus (NASDAQ:BVS)

3. Ironwood Pharmaceuticals (NASDAQ:IRWD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Spok Holdings (NASDAQ:SPOK)

3. Oramed Pharmaceuticals (NASDAQ:ORMP)

1. Embecta (NASDAQ:EMBC)

2. Nutex Health (NASDAQ:NUTX)

3. Organon & Co (NYSE:OGN)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.